Calciphylaxis is a rare, life-threatening complication, commonly seen in patient undergoing dialysis. The conditions if untreated lead to severe blood clots, painful skin ulcers, and serious infections. The conditions also affect patients in earlier stages of chronic kidney disease and is associated with substantial morbidity and mortality. Over the past few years, rapid strides have been made in the treatments based on ... Read more
The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level.
The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level.
The global market for calciphylaxis treatment can be categorized on ... Read more
The rising prevalence of calcific uremic arteriolopathy (CUA) in patients with renal failure, this can be important factor influencing demand for the global calciphylaxis treatment market. This condition is also recognized in the patient diagnosed with the non-uremic patients. This can be another key reason for the market growth at global level.
